{"ok":true,"route":"/api/pharma-collider","mode":"PHARMA_COLLIDER","description":"Collide pharmaceutical agents through the Contact Hamiltonian to discover synergies, antagonisms, and novel compounds","library":["alzr1-nanoparticle","parpi-olaparib","slfn11-modulator","ocrelizumab","siponimod","memantine","lecanemab","donanemab","cancer-ungoverned-surplus","slfn11-gate-restorer","parpi-governed","echo-tissue-reinstatement"],"alzr1":{"pid":{"K_p":4.2,"K_i":0.18,"K_d":1.1},"lyapunov":{"variance_reduction":0.999,"go_cycle":261},"rounds":["R2","R3","R4"]},"authority":"Joshua Lopez — DCGP.AI — USPTO 64/095,248"}